Sign in to view content

Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch

Estephania Feria, MD

Video
Published 2019

Related

Impact of Race on Vision Outcomes in RanibizumabTreated Patients With Diabetic Macular Edema: A Meta-Analysis of 5 Clinical Trial
M. Ali Khan, MD, FACS, FASRS
Updates from the Field
2021
Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema: 36-Week Results From the Phase 2 BOULEVARD Clinical Trial
Rishi P. Singh, MD
Annual Meeting Talks
2018
Part 2: Telemedicine for Diabetic Retinopathy Screening
Jose Agustin Martinez, MD
On Demand Cases, Courses, and Papers
2017

Category: AMD-Neovascular

See more